from Reuters: Health News https://ift.tt/3bY2tW4
Friday, 21 February 2020
FDA approves Lundbeck's migraine prevention therapy
The U.S. Food and Drug Administration approved Lundbeck A/S' migraine prevention therapy, which the Danish drugmaker acquired through its near $2 billion deal for Alder BioPharmaceuticals in 2019, the company said on Friday.
from Reuters: Health News https://ift.tt/3bY2tW4
from Reuters: Health News https://ift.tt/3bY2tW4
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment